Publications

September 2009
Teaching Note

iZumi (TN)

By: Robert F. Higgins

Teaching Note for [809105]. View Details

Keywords: Perspective; Intellectual Property; Venture Capital; Innovation and Invention; Investment; Financing and Loans; Information Technology; Mergers and Acquisitions; Commercialization; Biotechnology Industry

December 2004 (Revised July 2005)
Case

Focuses on the search for opportunity, the generation and evaluation of business concepts, creation of a business plan, and the start-up process. Follows experienced entrepreneur Christy Jones as she combines her business skills and personal experience to generate new... View Details

Keywords: Opportunities; Business Plan; Entrepreneurship; Personal Development and Career; Social Issues; Gender; Business Startups; Biotechnology Industry

June 2003 (Revised October 2003)
Case

Institut Pasteur

The Pasteur Institut is implementing a proactive commercialization strategy under the direction of Christian Policard. Highlights the government's innovation policy and the role that the Pasteur Institut can play in shaping it. Also addresses issues relating to higher... View Details

Keywords: Commercialization; Research and Development; Biotechnology Industry; France

October 2001 (Revised March 2008)
Case

Anagene, Inc.

By: Robert S. Kaplan and Christina L. Darwall

An entrepreneurial, publicly traded biotech company has begun production and sales of its core product--cartridges that permit DNA samples to be analyzed on a microchip. In the early quarters, sales are difficult to forecast and the company has experienced fluctuating... View Details

Keywords: Cost Accounting; Financial Reporting; Production; Performance Capacity; Risk and Uncertainty; Genetics; Governing and Advisory Boards; Biotechnology Industry; California

February 1994
Case

Alpha-Beta Technology, Inc.: Pioneering Carbohydrate Technology

Alpha-Beta was founded in 1988 by two scientist-entrepreneurs with ten patents on carbohydrate technology. In 1991, the company faces critical questions about how to focus its product definition from among several promising, but risky, choices. How should they analyze... View Details

Keywords: Technological Innovation; Product Design; Entrepreneurship; Product Development; Biotechnology Industry

Find at Harvard

November 1978 (Revised October 1989)
Case

Amicon Corp. (A)

Amicon holds a patent on a new process for the separation of blood plasma from whole blood. It has to decide whether to pursue a direct entry, joint venture, or licensing strategy. If it chooses licensing, there are many sub-issues to consider. View Details

Keywords: Technology; Patents; Commercialization; Health Care and Treatment; Biotechnology Industry

October 1987
Case

T Cell Sciences, Inc.

By: Francis Aguilar

Keywords: Biotechnology Industry

Find at Harvard

05 Dec 2013
Op-Ed

Encourage Breakthrough Health Care by Competing on Products Rather Than Patents

Like many people interested in the tangled connections between health care progress and intellectual property rights, I avidly followed the Myriad Genetics case, decided by the Supreme Court this June 13. In sum, molecular diagnostics maker Myriad sought "the... View Details

Keywords: by Richard G. Hamermesh; Biotechnology; Biotechnology

26 Jul 2024
Research & Ideas

Why Great Ideas Get Stuck in Universities

Entrepreneurs must overcome many barriers to get discoveries to market, but academic researchers face an additional one they might not realize: themselves. Academics tend to develop a myopic focus on the unique expertise they spend their lives developing, but that... View Details

Keywords: by Ben Rand; Biotechnology; Biotechnology

May 1999
Teaching Note

Elliot Lebowitz TN

By: Paul A. Gompers

Teaching Note for (9-297-094). View Details

Keywords: Biotechnology Industry

January 1998 (Revised September 2001)
Case

Genset: 1989

By: Paul A. Gompers and Amy Burroughs

Discusses the start-up strategy at Genset, a French biotech firm. Pascal Brandys, a venture capitalist, and Marc Vasseur, a leading French scientist, must decide how to proceed. Future real options are central to the strategy. View Details

Keywords: Strategy; Venture Capital; Business Startups; Biotechnology Industry; France

June 1997 (Revised September 1997)
Case

Genset Initial Public Offering (B)

By: Paul A. Gompers and Jeffrey M. Anapolsky

Supplements the (A) case. View Details

Keywords: Business Model; Initial Public Offering; Genetics; Going Public; Management Teams; Biotechnology Industry; France; United States

November 2016
Case

Anthony Starks at InSiL Therapeutics (A)

By: Gary Pisano and Vicki Sato

When Bruce Wayne hired Anthony Starks, he thought he had hit a home run by getting the most brilliant and passionate scientist-leader in the field to be his CSO. But a few months in, Wayne and Starks begin to clash over crucial forward-looking decisions about the... View Details

Keywords: Biotech; Silicon; Managing Innovation; Management Challenges; Managing People; Managing Organization; R＆D; R＆D Project Management; Platform; Venture Capital; Drug Discovery; management; Biotechnology Industry; California

January 2012 (Revised August 2012)
Case

Dirigo International

By: Christopher M. Gordon and Chad M. Carr

Dirigo International is proposing a major expansion of their life sciences research and manufacturing facilities in the heart of a major city and middle to lower income residential neighborhood. The company and city government are seeking a development solution in the... View Details

Keywords: Production; Property; Expansion; Governing Rules, Regulations, and Reforms; Business and Government Relations; Research and Development; Outcome or Result; Biotechnology Industry

August 2010 (Revised August 2012)
Supplement

Generation Health: A Pioneer in Genetics Benefit Management (B)

By: Robert F. Higgins

Keywords: Health; Research and Development; Biotechnology Industry

January 2010 (Revised August 2011)
Case

Ganeden Biotech, Inc.

By: Robert C. Pozen, Dale Alan Winger and Matthew Kenneth Ahlers

The CEO of Ganeden Biotech, a small firm with several viable probiotic products but limited resources, must decide what markets to invest in and what intellectual property strategies will best serve its immediate and longer-term business interests. View Details

Keywords: Entrepreneurship; Investment; Intellectual Property; Market Entry and Exit; Business Strategy; Biotechnology Industry

November 2009 (Revised March 2010)
Case

Managing Drugs on the Forefront of Personalized Medicine: The Erbitux and Vectibix Story

By: Richard G. Hamermesh, Raju Kucherlapati and Rachel Gordon

In May 2007, Amgen Inc. (Amgen) received disappointing news from the European Medicines Agency (EMEA) that its drug Vectibix, developed to fight metastatic colorectal cancer, had been rejected. This was especially surprising news given that a similar rival drug had... View Details

Keywords: Entrepreneurship; Governing Rules, Regulations, and Reforms; Health Testing and Trials; Marketing Strategy; Product Positioning; Genetics; Biotechnology Industry; Europe; United States